Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Journal of Materials Chemistry. B|July 5, 2022
Ångstrom-scale silver particles potently combat SARS-CoV-2 infection by suppressing the ACE2 expression and inflammatory responsesYong-Qiang Deng, Zhen-Xing Wang, Xin Liu, et al.
International Journal of Cancer|April 4, 2017
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trialMarta Schirripa, Wu Zhang, Volker Heinemann, et al.
Clinical Colorectal Cancer|September 17, 2018
Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal CancerYu Sunakawa, Dongyun Yang, Shu Cao, et al.
Applied Microbiology and Biotechnology|June 4, 2026
Rational development of an mRNA antibody cocktail with extended therapeutic window against ricin intoxicationMei Wu, Xi Luo, Pei-Yu Jiang, et al.
Nature Communications|August 28, 2025
Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screeningMeng-Qi Li, Yan-Peng Xu, Kai Li, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsMartin D Berger, Yan Ning, Sebastian Stintzing, et al.
International Journal of Cancer|June 2, 2017
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancerSatoshi Okazaki, Sebastian Stintzing, Yu Sunakawa, et al.
Clinical Colorectal Cancer|April 3, 2018
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With RegorafenibMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/CetuximabMartin D Berger, Sebastian Stintzing, Volker Heinemann, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Pageof 16